Regulation of Monocyte Perilipin-2 Expression in Acute and Chronic Coronary Syndromes: Pathogenetic Implications
Authors:
- Francesco CanonicoFrancesco Canonico
- Renzo LaboranteRLRenzo Laborante
- Chiara PidoneCPChiara Pidone
- Ramona VinciRVRamona Vinci
- Mattia GalliMGMattia Galli
- Eugenia PisanoEPEugenia Pisano
- Alice BonanniABAlice Bonanni
- Marianna Di SarioMSMarianna Di Sario
- Anna SeverinoASAnna Severino
- Lucia LisiLLLucia Lisi
- Daniela PedicinoDPDaniela Pedicino
- Giovanna LiuzzoGLGiovanna Liuzzo
Open Access
- 30 September 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (19) , 9550
Abstract
PLIN2 is involved in the lipid metabolism of macrophages resident in atherosclerotic plaques, and its upregulation leads to lipid droplets (LDs) accumulation. LDs enlargement results in the macrophage transformation into foam cells, a key step for the onset of atherosclerosis. In the present study, we investigated the role of PLIN2 and its regulation mechanisms in atherosclerosis and plaque instability in patients with a diagnosis of ST-elevation myocardial infarction (STEMI) and chronic coronary syndrome (CCS). We enrolled STEMI (n = 122) and CCS patients (n = 45). Peripheral blood mononuclear cells were isolated from whole blood samples. The PLIN2 protein level was analyzed in CD14+ monocytes by flow cytometry. Lipidomic panel and proteasome activity were evaluated. PLIN2 protein expression was significantly correlated with the age of CAD patients. We found no significant difference in monocyte lipid content between the two patient groups. The PLIN2 increased in STEMI as compared to CCS patients (p < 0.001). The proteasome activity being higher in STEMI as compared to CCS patients (p < 0.001), significant inverse correlations were evident between PLIN2 levels and proteasome activity in the CCS groups (p = 0.02). PLIN2 expression was higher in STEMI as compared to CCS patients, suggesting an involvement in plaque instability. Despite the proteasome activity being higher in STEMI patients, probably due to the elevated inflammatory burden, PLIN2 could escape proteasome degradation in a more efficient manner in STEMI as compared to CCS patients.Keywords
This publication has 37 references indexed in Scilit:
- Lipid-associated macrophages transition to an inflammatory state in human atherosclerosis, increasing the risk of cerebrovascular complicationsNature Cardiovascular Research, 2023
- Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management StrategiesJACC: Cardiooncology, 2023
- Upregulated monocyte expression of PLIN2 is associated with early arterial injury in children with overweight/obesityAtherosclerosis, 2021
- AtherosclerosisNature Reviews Disease Primers, 2019
- Inhibition of perilipin 2 expression reduces pro-inflammatory gene expression and increases lipid droplet sizeFood & Function, 2018
- Perilipin 2 levels are increased in patients with in-stent neoatherosclerosis: A clue to mechanisms of accelerated plaque formation after drug-eluting stent implantationInternational Journal of Cardiology, 2018
- Pathophysiology of Acute Coronary SyndromeCurrent Atherosclerosis Reports, 2014
- Adipophilin affects the expression of TNF-α, MCP-1, and IL-6 in THP-1 macrophagesMolecular and Cellular Biochemistry, 2009
- Using Peripheral Blood Mononuclear Cells to Determine Proteome Profiles in Human Cardiac FailureEuropean Journal of Heart Failure, 2008
- Atherosclerotic plaque rupture – pathologic basis of plaque stability and instabilityCardiovascular Research, 1999